L-3-(3,4-Dihydroxyphenyl)alanine (CAS 65170-01-6) — formula C9H11NO4, molecular weight 197.19; category organic chemicals.
| CAS Number | 65170-01-6 |
|---|---|
| Molecular Formula | C9H11NO4 |
| Molecular Weight | 197.19 |
| Melting Point | 295 |
| Boiling Point | 448.4 |
| LogP | 0.05 |
| Applications | Uses: Natural form of dopa (precursor of the catecholamines), Used to treat Parkinson's disease, [Merck Index], MEDICATION, Use (kg) in Switzerland (2009): >2500, Use (kg, approx.) in Germany (2009): >25000, Use (kg) in USA (2002): 26200, Use (kg) in France (2004): 24996, Consumption (g per capita) in Switzerland (2009): 0.32, Consumption (g per capita, approx.) in Germany (2009): 0.31, Consumption (g per capita) in the USA (2002): 0.093, Consumption (g per capita) in France (2004): 0.41, Excretion rate: 0.5, Calculated removal (%): 75.1, For the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication., Use Classification: Pharmaceuticals, Methods of Manufacturing: Derived from several types of beans including vanilla., Preparation from L-tyrosine: Vorbruggen, Krolikiewicz, Ber. 105, 1168 (1972), Bretschneider et al., Helv. Chim. Acta 56, 2857 (1973), from Vicia faba beans: Wysong, US 3253023 (1966 to Dow Chem.), by fermentation of L-tyrosine: Sih et al., J. Am. Chem. Soc. 91, 6204 (1969), Florent, Renaut, DE 2102793 (1971 to Rhone-Poulenc), C.A. 75, 108505f (1971). Separation from racemate: Vogler, Baumgartner, Helv. Chim. Acta 35, 1776 (1952), NL 6514950, US 3405159 (1966, 1968 both to Merck & Co.), Production: glycine + acetic anhydride + vanillin (amide formation, carbonyl condensation, chiral catalytic hydrogenation, hydrolysis. Production: 2, 4-dihydroxybenzaldehyde + hydrogen cyanide + ammonia (Strecker synthesis, racemate separation). Production: catechol + pyruvic acid + ammonia (microbial conversion), Formulations, Preparations: CAPSULES USP: 100, 250, & 500 MG, TABLETS USP: 100, & 500 MG., Levodopa is one of the main ingredients along with carbidopa in the drug Sinemet ... (tablets), Levodopa is one of the main ingredients along with carbidopa in the drug Atamet ... (tablets), General Manufacturing Information: L-Tyrosine, 3-hydroxy-: ACTIVE |
| Category | Organic Chemicals |
Documented applications: Uses: Natural form of dopa (precursor of the catecholamines), Used to treat Parkinson's disease, [Merck Index], MEDICATION, Use (kg) in Switzerland (2009): >2500, Use (kg, approx.) in Germany (2009): >25000, Use (kg) in USA (2002): 26200, Use (kg) in France (2004): 24996, Consumption (g per capita) in Switzerland (2009): 0.32, Consumption (g per capita, approx.) in Germany (2009): 0.31, Consumption (g per capita) in the USA (2002): 0.093, Consumption (g per capita) in France (2004): 0.41, Excretion rate: 0.5, Calculated removal (%): 75.1, For the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication., Use Classification: Pharmaceuticals, Methods of Manufacturing: Derived from several types of beans including vanilla., Preparation from L-tyrosine: Vorbruggen, Krolikiewicz, Ber. 105, 1168 (1972), Bretschneider et al., Helv. Chim. Acta 56, 2857 (1973), from Vicia faba beans: Wysong, US 3253023 (1966 to Dow Chem.), by fermentation of L-tyrosine: Sih et al., J. Am. Chem. Soc. 91, 6204 (1969), Florent, Renaut, DE 2102793 (1971 to Rhone-Poulenc), C.A. 75, 108505f (1971). Separation from racemate: Vogler, Baumgartner, Helv. Chim. Acta 35, 1776 (1952), NL 6514950, US 3405159 (1966, 1968 both to Merck & Co.), Production: glycine + acetic anhydride + vanillin (amide formation, carbonyl condensation, chiral catalytic hydrogenation, hydrolysis. Production: 2, 4-dihydroxybenzaldehyde + hydrogen cyanide + ammonia (Strecker synthesis, racemate separation). Production: catechol + pyruvic acid + ammonia (microbial conversion), Formulations, Preparations: CAPSULES USP: 100, 250, & 500 MG, TABLETS USP: 100, & 500 MG., Levodopa is one of the main ingredients along with carbidopa in the drug Sinemet ... (tablets), Levodopa is one of the main ingredients along with carbidopa in the drug Atamet ... (tablets), General Manufacturing Information: L-Tyrosine, 3-hydroxy-: ACTIVE.
L-3-(3,4-Dihydroxyphenyl)alanine is a carbon-based organic compound with CAS registry number 65170-01-6 and molecular formula C9H11NO4 (molecular weight 197.19), belonging to the organic chemicals segment of chemical raw materials.
CAS number: 65170-01-6
Its molecular formula C9H11NO4 comprises 9 C, 11 H, 1 N, 4 O atoms.
Also known as: L-3-(3,4-Dihydroxyphenyl)alanine · L-3-(3,4-二羟基苯基)丙氨酸
Category: organic chemicals
The CAS registry number of L-3-(3,4-Dihydroxyphenyl)alanine is 65170-01-6.
Molecular formula C9H11NO4, molecular weight 197.19.
It is also registered under: L-3-(3,4-Dihydroxyphenyl)alanine, L-3-(3,4-二羟基苯基)丙氨酸.
Recorded applications: Uses: Natural form of dopa (precursor of the catecholamines), Used to treat Parkinson's disease, [Merck Index], MEDICATION, Use (kg) in Switzerland (2009): >2500, Use (kg, approx.) in Germany (2009): >25000, Use (kg) in USA (2002): 26200, Use (kg) in France (2004): 24996, Consumption (g per capita) in Switzerland (2009): 0.32, Consumption (g per capita, approx.) in Germany (2009): 0.31, Consumption (g per capita) in the USA (2002): 0.093, Consumption (g per capita) in France (2004): 0.41, Excretion rate: 0.5, Calculated removal (%): 75.1, For the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication., Use Classification: Pharmaceuticals, Methods of Manufacturing: Derived from several types of beans including vanilla., Preparation from L-tyrosine: Vorbruggen, Krolikiewicz, Ber. 105, 1168 (1972), Bretschneider et al., Helv. Chim. Acta 56, 2857 (1973), from Vicia faba beans: Wysong, US 3253023 (1966 to Dow Chem.), by fermentation of L-tyrosine: Sih et al., J. Am. Chem. Soc. 91, 6204 (1969), Florent, Renaut, DE 2102793 (1971 to Rhone-Poulenc), C.A. 75, 108505f (1971). Separation from racemate: Vogler, Baumgartner, Helv. Chim. Acta 35, 1776 (1952), NL 6514950, US 3405159 (1966, 1968 both to Merck & Co.), Production: glycine + acetic anhydride + vanillin (amide formation, carbonyl condensation, chiral catalytic hydrogenation, hydrolysis. Production: 2, 4-dihydroxybenzaldehyde + hydrogen cyanide + ammonia (Strecker synthesis, racemate separation). Production: catechol + pyruvic acid + ammonia (microbial conversion), Formulations, Preparations: CAPSULES USP: 100, 250, & 500 MG, TABLETS USP: 100, & 500 MG., Levodopa is one of the main ingredients along with carbidopa in the drug Sinemet ... (tablets), Levodopa is one of the main ingredients along with carbidopa in the drug Atamet ... (tablets), General Manufacturing Information: L-Tyrosine, 3-hydroxy-: ACTIVE.
Category: Organic Chemicals.
Independent reference data for L-3-(3,4-Dihydroxyphenyl)alanine (CAS 65170-01-6), compiled from public chemistry databases.
| CAS Registry Number | 65170-01-6 |
|---|---|
| PubChem CID | 6047 |
| Molecular formula | C9H11NO4 |
| IUPAC name | (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid |
| UNII (FDA) | 46627O600J |
| Molecular Weight | 197.19 |
|---|---|
| XLogP3 | -2.7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 197.06880783 |
| Monoisotopic Mass | 197.06880783 |
| Topological Polar Surface Area | 104 |
| Heavy Atom Count | 14 |
| Boiling Point | 448.4 |
|---|---|
| Melting Point | 295 |
| Melting Point | 284-286 °C |
| Melting Point | 285 °C |
| Solubility | 5mM |
| Solubility | In water, 5,000 mg/l @ 20 °C |
| Solubility | 5.0 mg/mL |
| LogP | 0.05 |
| LogP | log Kow = -2.39 |
| LogP | -2.39 |
levodopa; L-dopa; 59-92-7; 3,4-dihydroxy-L-phenylalanine; Dopar; 3-Hydroxy-L-tyrosine; Larodopa; Bendopa; 3-(3,4-Dihydroxyphenyl)-L-alanine; Levopa; Brocadopa; Dopaidan; Dopalina; Dopasol; Eldopal; Insulamina
| Reported hazard statements | H302 (100%), H315 (32.2%), H319 (52.9%), H335 (30.8%), H361 (30.3%), H372 (14.4%), H411 (26.9%), H412 (15.9%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (32.2%): Causes skin irritation [Warning Skin corrosion/irritation]
L-3-(3,4-Dihydroxyphenyl)alanine · CAS 65170-01-6 · C9H11NO4. UNII 46627O600J. Boiling Point: 448.4; Melting Point: 295; Melting Point: 284-286 °C.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: L-3-(3,4-二羟基苯基)丙氨酸